« Previous
Next »
Clinical Imaging
Volume 35, Issue 4
, Pages 288-293
, July 2011
Magnetic resonance spectroscopic imaging of benign prostatic tissue: findings at 3.0 T compared to 1.5 T—initial experience
References
- . Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J. Urol. 2003;170:S69–S76
- . Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance?. Radiology. 2008;247:444–450
- . Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. Radiology. 2007;245:499–506
- . Echo-time independent signal modulations using PRESS sequences: a new approach to spectral editing of strongly coupled AB spin systems. J Magn Reson. 2005;177:299–306
- . Improved solvent suppression and increased spatial excitation bandwidths for three-dimensional PRESS CSI using phase-compensating spectral/spatial spin-echo pulses. J Magn Reson Imaging. 1997;7:745–757
- . Dualband spectral–spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med. 2001;46:1079–1087
- Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med. 2000;43:23–33
- . High-speed 3T MR spectroscopic imaging of prostate with flyback echo-planar encoding. J Magn Reson Imaging. 2007;25:1288–1292
- . Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol. 2000;164:400–404
- . Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology. 2004;233:701–708
- Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T. Magn Reson Med. 2005;53:1033–1039
- Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med. 2003;50:944–954
- Quantitative analysis of prostate metabolites using (1)H HR-MAS spectroscopy. Magn Reson Med. 2006;55:1257–1264
- . Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future?. Top Magn Reson Imaging. 2005;16:325–335
- . Body MR imaging at 3.0 T: understanding the opportunities and challenges. Radiographics. 2007;27:1445–1462
- . Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med. 2001;45:765–769
- . Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol. 2007;84:63–69
- . Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR Am J Roentgenol. 2005;185:1471–1476
- . Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. Radiology. 2007;244:797–806
☆ ACW was supported by NIBIB T32 training grant 1 T32 EB001631.
PII: S0899-7071(10)00151-8
doi: 10.1016/j.clinimag.2010.07.005
« Previous
Next »
Clinical Imaging
Volume 35, Issue 4
, Pages 288-293
, July 2011
